**BREAKING NEWS — 14 February 2025**

BREAKING NEWS — 14 February 2025

What: A controversial new pharmaceutical initiative, provisionally dubbed “TrumpRx,” has been announced by former President Donald Trump and a consortium of private investors.

Who: Former U.S. President Donald J. Trump, alongside pharmaceutical executives and political allies, unveiled the plan during a press conference at his Mar-a-Lago residence. Regulatory oversight will fall to the Food and Drug Administration and the Federal Trade Commission.

When: The formal announcement occurred at 11:00 AM Eastern Standard Time today.

Where: The announcement was made at Mar-a-Lago, Palm Beach, Florida. Distribution of the proposed drug is currently slated to begin in select pharmacies across Ohio, Florida, and Texas by the third quarter of this year.

Why: According to the press release, the program aims to lower prescription drug costs for senior citizens and veterans by introducing a generic competitor to a widely-used class of cholesterol medications. Critics, however, allege the initiative is a thinly-veiled branding exercise designed to bolster the former president’s political profile ahead of the 2028 election cycle.

How: The TrumpRx plan leverages bulk purchasing agreements and direct-to-consumer telehealth prescriptions, bypassing traditional insurance middlemen. Patent details and pricing data have not yet been disclosed pending federal antitrust review. The Federal Trade Commission has confirmed it will investigate potential conflicts of interest, given the former president’s ongoing business holdings.